title: Response.
authors.affiliation: : Department of Medical Oncology, Prince of Wales Hospital, NSW, Australia (DG);HonorHealth and The Translational Genomics Research Institute (TGen), Scottsdale, AZ (DVH). d.goldstein@unsw.edu.au.
authors.forename: David
authors.initials: D
authors.lastname: Goldstein
authors.affiliation: : Department of Medical Oncology, Prince of Wales Hospital, NSW, Australia (DG);HonorHealth and The Translational Genomics Research Institute (TGen), Scottsdale, AZ (DVH).
authors.forename: Daniel
authors.initials: D
authors.lastname: Von Hoff
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*